Toyoda Gosei Co., Ltd.
Toyoda Gosei Co., Ltd. (TGOSY) Financial Performance & Income Statement Overview
Review Toyoda Gosei Co., Ltd. (TGOSY) income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns.
Toyoda Gosei Co., Ltd. (TGOSY) Income Statement & Financial Overview
Explore comprehensive income reports for Toyoda Gosei Co., Ltd. TGOSY, broken down by year and quarter.
| Metric | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 |
|---|---|---|---|---|
| Revenue | $272.84B | $271.02B | $251.60B | $264.33B |
| Cost of Revenue | $226.85B | $231.30B | $216.17B | $225.13B |
| Gross Profit | $45.99B | $39.72B | $35.43B | $39.20B |
| Gross Profit Ratio | $0.17 | $0.15 | $0.14 | $0.15 |
| R&D Expenses | $0.00 | $0.00 | $0.00 | $0.00 |
| SG&A Expenses | $24.42B | $22.20B | $22.58B | $22.60B |
| Operating Expenses | $24.42B | $21.51B | $22.58B | $21.98B |
| Total Costs & Expenses | $251.28B | $252.81B | $238.75B | $247.11B |
| Interest Income | $1.37B | $0.00 | $1.45B | $1.73B |
| Interest Expense | $5.21B | $0.00 | $6.44B | $959.00M |
| Depreciation & Amortization | $13.52B | $13.33B | $13.13B | $13.27B |
| EBITDA | $27.66B | $31.54B | $26.23B | $30.49B |
| EBITDA Ratio | $0.10 | $0.12 | $0.10 | $0.12 |
| Operating Income | $21.57B | $18.21B | $12.85B | $17.22B |
| Operating Income Ratio | $0.08 | $0.07 | $0.05 | $0.07 |
| Other Income/Expenses (Net) | -$12.64B | $5.78B | -$6.19B | $1.14B |
| Income Before Tax | $8.93B | $23.99B | $6.66B | $18.36B |
| Income Before Tax Ratio | $0.03 | $0.09 | $0.03 | $0.07 |
| Income Tax Expense | $3.42B | $8.27B | -$387.00M | $4.92B |
| Net Income | $4.07B | $14.06B | $6.37B | $11.84B |
| Net Income Ratio | $0.01 | $0.05 | $0.03 | $0.04 |
| EPS | $31.98 | $110.57 | $50.15 | $93.20 |
| Diluted EPS | $31.98 | $110.57 | $50.15 | $93.20 |
| Weighted Avg Shares Outstanding | $127.11M | $127.13M | $127.03M | $127.03M |
| Weighted Avg Shares Outstanding (Diluted) | $127.11M | $127.13M | $127.04M | $127.03M |
Over the past four quarters, Toyoda Gosei Co., Ltd. demonstrated steady revenue growth, increasing from $264.33B in Q1 2024 to $272.84B in Q4 2024. Operating income reached $21.57B in Q4 2024, maintaining a consistent 8% margin over recent quarters. Despite fluctuations in R&D and SG&A expenses, EBITDA remained robust at $27.66B, reflecting operational efficiency. Net income dropped to $4.07B, with EPS at $31.98. Disciplined expense management helped sustain profitability, highlighting solid overall financial performance.
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan